← Back to Search

A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects (NP-PWD2 Trial)

N/A
Waitlist Available
Led By Rodney Chan, MD
Research Sponsored by The Metis Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up seven to nine days post application.
Awards & highlights
No Placebo-Only Group

Summary

This study will demonstrate the effectiveness of the NP-PWD therapy in managing complex wounds and improving wound healing parameters as compared to standard of care.

Eligible Conditions
  • Soft Tissue Injury
  • Dermabrasion

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~seven to nine days post application.
This trial's timeline: 3 weeks for screening, Varies for treatment, and seven to nine days post application. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility and usability of device in treatment.
Secondary study objectives
Ease of use of device by healthcare providers
Incidence of colony forming units.
Tolerability of the device by patient subjects
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: NP-PWD applicationExperimental Treatment1 Intervention
Patients randomized to NP-PWD arm will have the NP-PWD device applied to their wound.
Group II: Standard of Care Wound VAC applicationActive Control1 Intervention
Patients randomized to the standard of care arm will have the standard wound vac device applied to their wound.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NP-PWD
2019
N/A
~40

Find a Location

Who is running the clinical trial?

The Metis FoundationLead Sponsor
12 Previous Clinical Trials
724 Total Patients Enrolled
Rodney Chan, MDPrincipal InvestigatorThe Metis Foundation
4 Previous Clinical Trials
80 Total Patients Enrolled
~12 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top